ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 82 filers reported holding ANI PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $278,000 | -64.4% | 5,287 | -68.3% | 0.00% | -66.7% |
| Q2 2017 | $780,000 | +248.2% | 16,669 | +267.7% | 0.00% | +200.0% |
| Q1 2017 | $224,000 | -24.1% | 4,533 | -7.0% | 0.00% | 0.0% |
| Q4 2016 | $295,000 | -12.7% | 4,874 | -4.5% | 0.00% | 0.0% |
| Q3 2016 | $338,000 | +18.6% | 5,101 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $285,000 | +61.0% | 5,101 | -3.2% | 0.00% | 0.0% |
| Q1 2016 | $177,000 | -25.6% | 5,270 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $238,000 | +17.8% | 5,270 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $202,000 | -36.3% | 5,109 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $317,000 | +0.6% | 5,109 | +1.5% | 0.00% | 0.0% |
| Q1 2015 | $315,000 | +8.2% | 5,033 | -2.5% | 0.00% | 0.0% |
| Q4 2014 | $291,000 | +95.3% | 5,161 | -1.8% | 0.00% | 0.0% |
| Q3 2014 | $149,000 | -17.7% | 5,257 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $181,000 | – | 5,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |